Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Signal Transduction

Background:

• The transcription factor STAT3's role in hypertension-induced cardiac hypertrophy was previously unclear.
• Early research suggested STAT3 inhibition reduced hypertrophy but impaired cardiac function.
• Recent studies indicate STAT3 is protective, not causative, in cardiac hypertrophy.

Purpose of the Study:

• To clarify the complex role of STAT3 in cardiac pathophysiology.
• To investigate STAT3's function in metabolic homeostasis and response to cardiac stress.
• To explore STAT3's involvement in various heart conditions like myocarditis and cardiomyopathy.

Main Methods:

• Analysis of studies involving global STAT3 reduction.
• Investigation of cardiomyocyte-specific STAT3 deletion models.
• Examination of STAT3's role in viral and immune-mediated myocarditis.
• Exploration of non-canonical STAT3 signaling pathways (U-STAT3, redox-activated STAT3).

Main Results:

• STAT3 deletion in cardiomyocytes exacerbates cardiac hypertrophy and metabolic dysfunction.
• STAT3 maintains membrane integrity and opposes dilated cardiomyopathy in viral myocarditis.
• STAT3 can contribute to myocarditis through IL-6 signaling and Th17 cell differentiation.
• Non-canonical STAT3 pathways and cytokine signaling (IL-22, IL-17) involvement in cardiac function is emerging.

Conclusions:

• Cardiac STAT3 is crucial for metabolic homeostasis and protection against pathological insults.
• STAT3 exhibits dual roles in myocarditis, with both protective and detrimental effects depending on context.
• Further understanding of STAT3's multifaceted functions may reveal novel therapeutic targets for heart disease.